Impact Education, LLC, in collaboration with Postgraduate Institute for Medicine.
To register, please click the link at the bottom of this page.
Live Webcast Dates
| Wednesday, June 17, 2015 | 12:00 PM - 1:30 PM EDT |
| Thursday, July 16, 2015 | 12:00 PM - 1:30 PM EDT |
| Wednesday, July 22, 2015 | 12:00 PM - 1:30 PM EDT |
Hot Topics Include:
- Current and emerging therapies for the treatment of psoriasis and PsA
- Analysis of the available evidence-base for the treatment of psoriasis and PsA in a true comparative effectiveness research framework
- Nonadherence factors associated with various therapies for psoriasis and PsA
- Medical Directors and Pharmacy Directors from health plans, HMOs, integrated health systems, employers, quality organizations, and other managed care organizations (MCOs)
- Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for patients with multiple myeloma including: physicians, pharmacists, registered nurses, and case managers
|
Neal Birnbaum, MD, FACP, MACR Director, Division of Rheumatology California Pacific Medical Center Clinical Professor of Medicine University of California, San Francisco |
|
Jeff Dunn, PharmD, MBA Senior Vice President Chief Clinical Officer VRx Pharmacy Services, LLC |
|
Alan Menter, MD Chief, Division of Dermatology Baylor University Medical Center Chair, Psoriasis Guidelines Committee American Academy of Dermatology |
Program Overview
As novel agents become available to treat psoriatic disease, treatment decision making is becoming more complex. In light of new drug developments as well as expanding uses of current agents, managed care organizations (MCOs) and payer organizations need to appropriately and effectively design benefits that optimize both cost-efficiency and patient outcomes. This educational activity will include discussions and practical demonstrations of current and emerging clinical data, pharmacy benefit designs, and management resources for managed care professionals to consider.
Educational Objectives
After completing this activity, the participant should be better able to:
- Analyze the available evidence-base for the treatment of psoriasis and PsA in a true CER framework
- Assess current and emerging therapies for the treatment of psoriasis and PsA and cite their clinical trial data
- Address nonadherence factors associated with various therapies for psoriasis and PsA
- Integrate interventions to coordinate health plan and affiliated providers efforts in the health care reform era that will lead to better outcomes for patients with psoriasis and PsA
- Provide accurate and appropriate counsel as part of the managed care treatment team
- Provide appropriate care and counsel for patients and their families
Agenda
| Opening Comments |
|
Assessing the Clinical Benefits of Current and Evolving Therapies for the Treatment of Psoriatic Disease in a Managed Care Setting
Neal Birnbaum, MD Alan Menter, MD |
|
Applying Comparative Effectiveness Research (CER) as a Decision-Support Tool Jeffrey Dunn, PharmD, MBA |
|
Best Practice Tips and Tools to Implement New Care Models Jeffrey Dunn, PharmD, MBA |
|
Audience Q&A Session Evaluation and Post-Activity Survey |
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Annenberg Center for Health Sciences at Eisenhower and Impact Education, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 |
Pharmacist Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Credit Designation
This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Activity #0797-9999-15-005-L04-P. This program is designated for up to 1.5 contact hours (0.15 CEUs) of continuing pharmacy education credit.
Type of Activity: Knowledge
Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.
Nursing Accreditation Statement
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Credit Designation
A maximum of 1.5 contact hours may be earned for successful completion of this activity.
A statement of credit will be issued only upon receipt of a completed activity evaluation form.
Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.x, and Google Chrome 10 and up
Fee Information
No additional fee is required to attend this activity.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.
Click here to register